Business Week -- GlaxoSmithKline PLC says it has signed a strategic alliance with South Korea’s Dong-A Pharmaceuticals Co., acquiring a 9.9 percent stake for 73.9 million pounds ($109.5 million).
Business Week -- GlaxoSmithKline PLC says it has signed a strategic alliance with South Korea’s Dong-A Pharmaceuticals Co., acquiring a 9.9 percent stake for 73.9 million pounds ($109.5 million).
